Vorinostat—An Overview

Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Curre...

Descripción completa

Detalles Bibliográficos
Autor principal: Bubna, Aditya Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
E-IJD Residents' Page
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533557/
https://www.ncbi.nlm.nih.gov/pubmed/26288427
http://dx.doi.org/10.4103/0019-5154.160511
_version_ 1782385357906509824
author Bubna, Aditya Kumar
author_facet Bubna, Aditya Kumar
author_sort Bubna, Aditya Kumar
collection PubMed
description Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Currently apart from cutaneous T cell lymphoma the role of Vorinostat for other types of cancers is being investigated both as mono-therapy and combination therapy.
format Online
Article
Text
id pubmed-4533557
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45335572015-08-18 Vorinostat—An Overview Bubna, Aditya Kumar Indian J Dermatol E-IJD Residents' Page Vorinostat is a new drug used in the management of cutaneous T cell lymphoma when the disease persists, gets worse or comes back during or after treatment with other medicines. It is an efficacious and well tolerated drug and has been considered a novel drug in the treatment of this condition. Currently apart from cutaneous T cell lymphoma the role of Vorinostat for other types of cancers is being investigated both as mono-therapy and combination therapy. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4533557/ /pubmed/26288427 http://dx.doi.org/10.4103/0019-5154.160511 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle E-IJD Residents' Page
Bubna, Aditya Kumar
Vorinostat—An Overview
title Vorinostat—An Overview
title_full Vorinostat—An Overview
title_fullStr Vorinostat—An Overview
title_full_unstemmed Vorinostat—An Overview
title_short Vorinostat—An Overview
title_sort vorinostat—an overview
topic E-IJD Residents' Page
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533557/
https://www.ncbi.nlm.nih.gov/pubmed/26288427
http://dx.doi.org/10.4103/0019-5154.160511
work_keys_str_mv AT bubnaadityakumar vorinostatanoverview

Ejemplares similares